1st International Symposium on Industry-academia Interaction in Advanced Biotechnology & Drug Discovery
Noida, Nov 22-23, 2010.
ORGANIZED BY
Society for Learning, Education, & Rehabilitation for Needy (S-LEARN), India, CloneGen Biotechnology, Noida, India & CloneGen Biotechnology, LLC, USA
The society of learning education, and rehabilitation for needy (S-LEARN) and Clonegen Biotechnology, Noida, organized the 1st International Symposium on Industry-academia interaction in advanced biotechnology & drug discovery at the premises of Clonegen Biotechnology during Nov 22-23, 2010. Dr. Ajit Srivastava , Executive Director , Esperion Therapeutics , USA served as the organizing secretary, who also gave an state- of- the- art lecture on the unmet medical need of patients who have metabolic syndrome , characterized by insulin resistance , low HDL and high triglycerides. The incidence of diabetes in India is increasing at an alarming rate and the diabetic patients are at the greater risk of developing cardiovascular diseases. The focus of the Symposium was on diabetes and cardiovascular diseases and ways to discover new chemical entity for the treatment of diseases. Dr. Ajit Srivastava’s presentation focused on the ways to enhance the removal process of the cholesterol from the body by raising functional HDL. Many renowned and accomplished Professors , scientists and successful entrepreneurs from the US, Canada, and India presented cutting edge science and tips to how to apply science and technology to help society through entrepreneurial efforts. Some of the notable presentations were keynote address by Dr. Mahmood Hussain , professor at State University of New York, USA who talked about how the main metabolic organ of our body , liver, regulates lipid metabolism. He described some of the studies from his recently published work in a renowned journal Cell Metabolism. Professor Pramod Rath from JNU, talked about how inflammation triggers and promotes lipid deposition in the arterial wall and causes heart disease. Prof D K Srivastava form the North Dakota University, USA talked about novel ways for the targeted delivery of drug to treat cancer and other chronic diseases by making use of modified enzymes. Prof Khosrow Adeli , from The University of Toronto , Canada gave an excellent presentation how the consumption of fructose-rich drinks like coke has contributed to the increase in the incidence of insulin resistance , diabetes , and obesity. He described the dysregulation of the pathways that leads to this derangement. Dr Kalyan Handique, founder of HandyLab, USA, and now Vice President BD Diagnostics, USA, gave an inspirational talk “An entrepreneurial journey into biotech: the Handylab Experience”. An excellent presentation was given by Dr. Roger Newton, president and CEO, Esperion Therapeutics, USA. Dr. Newton is a co discoverer of Lipitor, a drug that lower cholesterol and has helped hundreds and millions of patients around the world and sells for 12 billion dollars every year. Dr. Newton also started a new company that focused on a novel approach of regressing arterial lipids when a formulated HDL is infused into patient with lipid deposition in the arteries. Dr. Newton’s talk was well received by the audience, and students participating in the symposium had great time interacting with those who were present to give their talk and those who presented through web based video. The 2nd Symposium will be held next year around same time and will be organized for the larger audience.
Dr. Ajit Srivastava, PhD, FAHA,MBA
Click Here to Download 1st International Symposium Proceedings
